Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2020
What do the next five years have in store for the European Medicines Agency?
Dutch institutions failing to register results of clinical trials
COVID-19 risks turning back the clock on years of essential development work
Reflections on the World Health Assembly
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
In defence of WHO
HAI Follows Dutch Government Advice in Response to COVID-19
HAI Recognised for Commitment to Gender Equality
2019
A Momentous Week for Access to Medicines
Welcome to the new look website!
Dr Marg Ewen Receives the Helen Clark-JoPPP Award
2018
Staff Spotlight: Jaume Vidal
How WHO’s Internship Policy Became More Inclusive
A Week of Promise for Access to Medicines
What Role Can Civil Society Play in the European Regulatory Process?
Open Science for Health: Shaping the New Framework Programme
2017
EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines
Facing a Global Threat – Roadmap to Combat Antimicrobial Resistance and the Bumps Along the Way
The Forgotten Victims of Snakebite
Giving Snakebite Victims a Voice
Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy
European Commission Appoints Health Action International to HTA Network Stakeholder Pool
2016
Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit
‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69
Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event
2015